Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01508 | 34717194 | Int Immunopharmacol | Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB. | 2021 | Details |
| A01509 | 34717002 | Hepatology | Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling. | 2021 | Details |
| A01510 | 34716911 | Hormones (Athens) | Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A01511 | 34715296 | Free Radic Biol Med | Role of vitamin E in the treatment of non-alcoholic steatohepatitis. | 2021 | Details |
| A01512 | 34712920 | iScience | A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease. | 2021 | Details |
| A01513 | 34712528 | Cureus | An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders. | 2021 | Details |
| A01514 | 34712448 | Middle East J Dig Dis | Melatonin Levels in Patients with Nonalcoholic Fatty Liver Disease Compared with Healthy Individuals according to Fibrosis Level. | 2021 | Details |
| A01515 | 34712447 | Middle East J Dig Dis | Evaluating Pancreatic index in Patients with and without Metabolic Syndrome. | 2021 | Details |
| A01516 | 34712025 | World J Gastroenterol | Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. | 2021 | Details |
| A01517 | 34711912 | Sci Rep | Loss of hepatic Flcn protects against fibrosis and inflammation by activating autophagy pathways. | 2021 | Details |
| A01518 | 34711595 | BMJ Open | Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study. | 2021 | Details |
| A01519 | 34710938 | Z Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures. | 2021 | Details |
| A01520 | 34710482 | J Hepatol | Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. | 2021 | Details |
| A01521 | 34710382 | Am J Pathol | A Novel Mouse Model of Nonalcoholic Steatohepatitis Suggests that Liver Fibrosis Initiates around Lipid-Laden Macrophages. | 2021 | Details |
| A01523 | 34708234 | Sheng Li Xue Bao | [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression]. | 2021 | Details |
| A01524 | 34708231 | Sheng Li Xue Bao | [The role of SIRT6 in nonalcoholic steatohepatitis]. | 2021 | Details |
| A01525 | 34708066 | Front Nutr | Integrated Transcriptomic and Translatomic Inquiry of the Role of Betaine on Lipid Metabolic Dysregulation Induced by a High-Fat Diet. | 2021 | Details |
| A01526 | 34707711 | Exp Ther Med | MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis. | 2021 | Details |
| A01527 | 34707687 | Therap Adv Gastroenterol | Safety of anti-TNF agents in patients with compensated cirrhosis: a case-control study. | 2021 | Details |
| A01528 | 34707622 | Front Immunol | Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A01529 | 34707573 | Front Endocrinol (Lausanne) | Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01530 | 34707570 | Front Endocrinol (Lausanne) | Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk. | 2021 | Details |
| A01532 | 34707258 | Nat Rev Gastroenterol Hepatol | Advancing the global public health agenda for NAFLD: a consensus statement. | 2021 | Details |
| A01533 | 34707201 | Sci Rep | Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II. | 2021 | Details |
| A01535 | 34706716 | Lipids Health Dis | Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. | 2021 | Details |
| A01536 | 34706656 | BMC Gastroenterol | Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors. | 2021 | Details |
| A01537 | 34706542 | J Agric Food Chem | Sulforaphane Regulates Glucose and Lipid Metabolisms in Obese Mice by Restraining JNK and Activating Insulin and FGF21 Signal Pathways. | 2021 | Details |
| A01538 | 34706243 | Cell Rep | Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease. | 2021 | Details |
| A01539 | 34705426 | ACS Nano | Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01540 | 34704339 | Trop Med Int Health | Hepatic steatosis is associated with anthropometry, cardio-metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans. | 2021 | Details |
| A01541 | 34704009 | Metabol Open | Favorable effects of Anethum graveolens on liver oxidative stress and cholesterol 7 alpha-hydroxylase levels in non-alcoholic fatty liver disease (NAFLD) rat models. | 2021 | Details |
| A01542 | 34704008 | Metabol Open | Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis. | 2021 | Details |
| A01543 | 34704005 | JHEP Rep | PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation. | 2021 | Details |
| A01544 | 34703257 | Diabetes Metab Syndr Obes | QSHY Granules Promote White Adipose Tissue Browning and Correct BCAAs Metabolic Disorder in NAFLD Mice. | 2021 | Details |
| A01545 | 34702329 | Diabetol Metab Syndr | Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease. | 2021 | Details |
| A01546 | 34699301 | Adipocyte | Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice. | 2021 | Details |
| A01547 | 34697932 | J Korean Med Sci | Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. | 2021 | Details |
| A01548 | 34697917 | Hepatol Commun | Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey-Based Study. | 2021 | Details |
| A01550 | 34697666 | Handb Exp Pharmacol | Obesity and Obstructive Sleep Apnea. | 2021 | Details |
| A01552 | 34697380 | Sci Rep | Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS. | 2021 | Details |
| A01553 | 34696656 | Xenobiotica | Transcription profiling of cadmium-exposed livers reveals alteration of lipid metabolism and predisposition to hepatic steatosis. | 2021 | Details |
| A01554 | 34695558 | J Nutr Biochem | Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction. | 2021 | Details |
| A01555 | 34695228 | Eur J Clin Invest | Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis. | 2021 | Details |
| A01556 | 34694070 | Mol Syst Biol | Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients. | 2021 | Details |
| A01557 | 34694029 | FASEB J | BTT-105 ameliorates hepatic fibrosis in non-alcoholic fatty liver animal model. | 2021 | Details |
| A01558 | 34694013 | Aliment Pharmacol Ther | Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis. | 2021 | Details |
| A01559 | 34693661 | Cancer Med | First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study. | 2021 | Details |
| A01560 | 34693553 | J Gastroenterol Hepatol | Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study. | 2021 | Details |
| A01561 | 34693238 | JHEP Rep | Non-invasive biomarkers of Fontan-associated liver disease. | 2021 | Details |
| A01562 | 34693236 | JHEP Rep | Non-alcoholic fatty liver disease: A patient guideline. | 2021 | Details |
| A01563 | 34692739 | Front Med (Lausanne) | Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. | 2021 | Details |
| A01564 | 34692725 | Front Med (Lausanne) | PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial. | 2021 | Details |
| A01565 | 34691178 | J Oncol | Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. | 2021 | Details |
| A01566 | 34690666 | Int J Public Health | Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis. | 2021 | Details |
| A01567 | 34690658 | J Taibah Univ Med Sci | Impact of standard treatment on the quality of life of non-alcoholic fatty liver disease patients. | 2021 | Details |
| A01568 | 34690105 | Rev Gastroenterol Mex (Engl Ed) | Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them. | 2021 | Details |
| A01569 | 34689770 | Lipids Health Dis | Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study. | 2021 | Details |
| A01570 | 34689689 | J Obstet Gynaecol | Non-alcoholic fatty liver disease in polycystic ovarian syndrome in Indian women. | 2021 | Details |
| A01571 | 34689362 | Hepatology | Switch-associated protein 70 protects against nonalcoholic fatty liver disease via suppression of TAK1. | 2022 | Details |
| A01572 | 34689159 | Cell Death Discov | HES5-mediated repression of LIGHT transcription may contribute to apoptosis in hepatocytes. | 2021 | Details |
| A01573 | 34688952 | Clin Gastroenterol Hepatol | Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease. | 2021 | Details |
| A01574 | 34688661 | J Biol Chem | A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. | 2021 | Details |
| A01575 | 34688168 | Curr Opin Pharmacol | Non-alcoholic fatty liver disease: Current therapeutic options. | 2021 | Details |
| A01576 | 34687281 | Liver Int | Risk factors for bleeding hepatocellular adenoma in a United States cohort. | 2021 | Details |
| A01577 | 34687092 | Biofactors | Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. | 2021 | Details |
| A01578 | 34686753 | Sci Rep | Clinically silent LINE 1 insertion in the PNPLA3 gene may impede genotyping of the p.I148M variant. | 2021 | Details |
| A01579 | 34686466 | J Integr Med | Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. | 2021 | Details |
| A01580 | 34686147 | BMC Gastroenterol | The liver steatosis severity and lipid characteristics in primary biliary cholangitis. | 2021 | Details |
| A01581 | 34685636 | Cells | Oxysterol 7-α Hydroxylase (CYP7B1) Attenuates Metabolic-Associated Fatty Liver Disease in Mice at Thermoneutrality. | 2021 | Details |
| A01582 | 34685614 | Cells | Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01583 | 34685496 | Cells | Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression. | 2021 | Details |
| A01584 | 34684698 | Molecules | Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome. | 2021 | Details |
| A01585 | 34684653 | Nutrients | Coffeeberry Activates the CaMKII/CREB/BDNF Pathway, Normalizes Autophagy and Apoptosis Signaling in Nonalcoholic Fatty Liver Rodent Model. | 2021 | Details |
| A01586 | 34684586 | Nutrients | Time-Restricted Feeding during Puberty Ameliorates Adiposity and Prevents Hepatic Steatosis in a Mouse Model of Childhood Obesity. | 2021 | Details |
| A01587 | 34684533 | Nutrients | Supplementation with a Specific Combination of Metabolic Cofactors Ameliorates Non-Alcoholic Fatty Liver Disease, Hepatic Fibrosis, and Insulin Resistance in Mice. | 2021 | Details |
| A01588 | 34684510 | Nutrients | Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. | 2021 | Details |
| A01589 | 34684463 | Nutrients | Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV. | 2021 | Details |
| A01590 | 34684455 | Nutrients | Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse Model. | 2021 | Details |
| A01591 | 34684404 | Nutrients | Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus. | 2021 | Details |
| A01592 | 34684371 | Nutrients | Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis. | 2021 | Details |
| A01593 | 34684339 | Nutrients | Ethanol Extract of Liriope platyphylla Root Attenuates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice via Regulation of Lipogenesis and Lipid Uptake. | 2021 | Details |
| A01594 | 34684335 | Nutrients | Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets. | 2021 | Details |
| A01595 | 34684094 | Medicina (Kaunas) | Non-Alcoholic Fatty Liver Disease and COVID-19-Two Pandemics Hitting at the Same Time. | 2021 | Details |
| A01596 | 34683439 | Microorganisms | Sex-Specific Associations between Gut Microbiome and Non-Alcoholic Fatty Liver Disease among Urban Chinese Adults. | 2021 | Details |
| A01597 | 34682795 | J Clin Med | Defining NASH from a Multi-Omics Systems Biology Perspective. | 2021 | Details |
| A01598 | 34682759 | J Clin Med | Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma. | 2021 | Details |
| A01599 | 34681787 | Int J Mol Sci | The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01600 | 34681759 | Int J Mol Sci | Histone Demethylase KDM7A Contributes to the Development of Hepatic Steatosis by Targeting Diacylglycerol Acyltransferase 2. | 2021 | Details |
| A01601 | 34681695 | Int J Mol Sci | Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity. | 2021 | Details |
| A01602 | 34681600 | Int J Mol Sci | Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling. | 2021 | Details |
| A01603 | 34681291 | Foods | Tebuconazole Fungicide Induces Lipid Accumulation and Oxidative Stress in HepG2 Cells. | 2021 | Details |
| A01604 | 34681228 | Pharmaceuticals (Basel) | Lipid-Lowering Bioactivity of Microalga Nitzschia laevis Extract Containing Fucoxanthin in Murine Model and Carcinomic Hepatocytes. | 2021 | Details |
| A01605 | 34681219 | Pharmaceuticals (Basel) | Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach. | 2021 | Details |
| A01606 | 34681193 | Pharmaceuticals (Basel) | Posidonia oceanica (L.) Delile Extract Reduces Lipid Accumulation through Autophagy Activation in HepG2 Cells. | 2021 | Details |
| A01607 | 34680608 | Biomedicines | The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral Treatments. | 2021 | Details |
| A01608 | 34680557 | Biomedicines | Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet. | 2021 | Details |
| A01609 | 34680522 | Biomedicines | Lipid Disorders in NAFLD and Chronic Kidney Disease. | 2021 | Details |
| A01610 | 34680518 | Biomedicines | The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease. | 2021 | Details |
| A01611 | 34680486 | Biomedicines | Nonalcoholic Fatty Liver Disease and the Kidney: A Review. | 2021 | Details |
| A01612 | 34680476 | Biomedicines | Genetics Is of the Essence to Face NAFLD. | 2021 | Details |